What's new in the topical treatment of allergic skin diseases

Current Opinion in Allergy and Clinical Immunology

Volumn 14, Issue 5, 2014, Pages 436-450

  Aslam, Imran ^a   Sandoval, Laura F ^a,c   Feldman, Steven R ^a,b,c  

^a Center for Dermatology Research   (United States)

^b Department of Pathology ^*  (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

atopic dermatitis; contact dermatitis; topical calcineurin inhibitors; topical corticosteroids; topical therapy

Indexed keywords

BLEACHING AGENT; CALCINEURIN INHIBITOR; CORTICOSTEROID; LIPOXIN A; OIL; UROCANIC ACID; ANTIINFLAMMATORY AGENT; LIPOXIN;

ATOPIC DERMATITIS; CORTICOSTEROID THERAPY; CREAM; EMULSION; HUMAN; MAINTENANCE THERAPY; PRIORITY JOURNAL; PUBLICATION; REVIEW; SKIN ALLERGY; TOPICAL TREATMENT; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, ATOPIC; DRUG EFFECTS; EVIDENCE BASED MEDICINE; IMMUNOLOGY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKIN; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; CALCINEURIN INHIBITORS; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, ATOPIC; EVIDENCE-BASED MEDICINE; HUMANS; LIPOXINS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SKIN; UROCANIC ACID;

EID: 84906938104     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000093     Document Type: Review

References (42)

1. Kaplan AP, Buckley RH, Mathews KP. Allergic skin disorders. JAMA 1987; 258:2900-2909.
2. Ring J, Alomar A, Bieber T, Deleuran M, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol 2012; 26:1045-1060.
3. Lucky AW, Biro FM, Simbartl LA, et al. Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study. J Pediatr 1997; 130:30-39.
4. Grimalt R, Mengeaud V, Cambazard F; Study Investigators' Group. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study. Dermatology 2007; 214:61-67.
5. Bourke J, Coulson I, English J. Guidelines for the management of contact dermatitis: an update. Br J Dermatol 2009; 160:946-954.
6. Belsito D, Wilson DC, Warshaw E, et al. A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis. J Am Acad Dermatol 2006; 55:40-46.
7. Sanchez-Borges M, Asero R, Ansotegui IJ, et al. Diagnosis and treatment of urticaria and angioedema: a worldwide perspective. World Allergy Organ J 2012; 5:125-147.
8. Danby SG, Chittock J, Brown K, et al. The effect of tacrolimus compared to betamethasone valerate on the skin barrier in volunteers with quiescent atopic dermatitis. Br J Dermatol 2013; 170:914-921.
9. Dahnhardt-Pfeiffer S, Dahnhardt D, Buchner M, et al. Comparison of effects of tacrolimus ointment and mometasone furoate cream on the epidermal barrier of patients with atopic dermatitis. J Dtsch Dermatol Ges 2013; 11:437-443.
10. Jensen JM, Weppner M, Dahnhardt-Pfeiffer S, et al. Effects of pimecrolimus compared with triamcinolone acetonide cream on skin barrier structure in atopic dermatitis: a randomized, double-blind, right-left arm trial. Acta Derm Venereol 2013; 93:515-519.
11. Torley D, Futamura M, Williams HC, et al. What's new in atopic eczema? An analysis of systematic reviews published in 2010-11. Clin Exp Dermatol 2013; 38:449-456.
12. Ucak H, Demir B, Cicek D, et al. Efficacy of topical tacrolimus for the treatment of persistent pruritus ani in patients with atopic dermatitis. J Dermatolog Treat 2013; 24:454-457.
13. Yarbrough KB, Neuhaus KJ, Simpson EL. The effects of treatment on itch in atopic dermatitis. Dermatol Ther 2013; 26:110-119.
14. Onumah N, Kircik L. Pimecrolimus cream and tacrolimus ointment in the treatment of atopic dermatitis: a pilot study on patient preference. J Drugs Dermatol 2013; 12:1145-1148.
15. Chung BY, Kim HO, Kim JH, et al. The proactive treatment of atopic dermatitis with tacrolimus ointment in Korean patients: a comparative study between once-weekly and thrice-weekly applications. Br J Dermatol 2013; 168:908-910.
16. Wu SH, Chen XQ, Liu B, et al. Efficacy and safety of 15(R/S)-methyl- lipoxin A(4) in topical treatment of infantile eczema. Br J Dermatol 2013; 168:172-178.
17. Hoppe T, Winge MC, Bradley M, et al. Moisturizing treatment of patients with atopic dermatitis and ichthyosis vulgaris improves dry skin, but has a modest effect on gene expression regardless of FLG genotype. J Eur Acad Dermatol Venereol 2013. [Epub ahead of print]
18. Boralevi F, Saint AM, Delarue A, et al. Long-term emollient therapy improves xerosis in children with atopic dermatitis. J Eur Acad Dermatol Venereol 2013. [Epub ahead of print]
19. Wananukul S, Chatproedprai S, Chunharas A, et al. Randomized, doubleblind, split-side, comparison study of moisturizer containing licochalcone A and 1% hydrocortisone in the treatment of childhood atopic dermatitis. J Med Assoc Thai 2013; 96:1135-1142.
20. Marini A, Reinelt K, Krutmann J, Bilstein A. Ectoine-containing cream in the treatment of mild to moderate atopic dermatitis: a randomised, comparatorcontrolled, intra-individual double-blind, multicenter trial. Skin Pharmacol Physiol 2014; 27:57-65.
21. Simpson E, Bohling A, Bielfeldt S, et al. Improvement of skin barrier function in atopic dermatitis patients with a new moisturizer containing a ceramide precursor. J Dermatolog Treat 2013; 24:122-125.
22. Hon KL, Leung AK, Barankin B. Barrier repair therapy in atopic dermatitis: an overview. Am J Clin Dermatol 2013; 14:389-399.
23. Danby SG, AlEnezi T, Sultan A, et al. Effect of olive and sunflower seed oil on the adult skin barrier: implications for neonatal skin care. Pediatr Dermatol 2013; 30:42-50.
24. Evangelista MT, Abad-Casintahan F, Lopez-Villafuerte L. The effect of topical virgin coconut oil on SCORAD index, transepidermal water loss, and skin capacitance in mild to moderate pediatric atopic dermatitis: a randomized, double-blind, clinical trial. Int J Dermatol 2014; 53:100-108.
25. Wong SM, Ng TG, Baba R. Efficacy and safety of sodium hypochlorite (bleach) baths in patients with moderate to severe atopic dermatitis in Malaysia. J Dermatol 2013; 40:874-880.
26. Peltonen JM, Pylkkanen L, Jansen CT, et al. Three randomised Phase I/IIa trials of 5% cis-urocanic acid emulsion cream in healthy adult subjects and in patients with atopic dermatitis. Acta Derm Venereol 2013; 94:415-420.
27. Araujo CP, Gomes J, Vieira AP, et al. A proposal for the use of new silverseaweed-cotton fibers in the treatment of atopic dermatitis. Cutan Ocul Toxicol 2013; 32:268-274.
28. Lopes C, Silva D, Delgado L, et al. Functional textiles for atopic dermatitis: a systematic review and meta-analysis. Pediatr Allergy Immunol 2013; 24: 603-613.
29. Futamura M, Masuko I, Hayashi K, et al. Effects of a short-term parental education program on childhood atopic dermatitis: a randomized controlled trial. Pediatr Dermatol 2013; 30:438-443.
30. Shah A, Yentzer BA, Feldman SR. Timing of return office visit affects adherence to topical treatment in patients with atopic dermatitis: an analysis of 5 studies. Cutis 2013; 91:105-107.
31. Di PF, Di ME, Di PG, et al. Poststeroid management of chronic vulvar itching with a topical formula containing natural antiitching and anti-inflammatory actives. Int J Womens Health 2013; 5:187-191.
32. Thaci D, Salgo R. Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies. Clin Dermatol 2010; 28:52-56.
33. Segal AO, Ellis AK, Kim HL. CSACI position statement: safety of topical calcineurin inhibitors in the management of atopic dermatitis in children and adults. Allergy Asthma Clin Immunol 2013; 9:24.
34. Siegfried EC, Jaworski JC, Hebert AA. Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice. Am J Clin Dermatol 2013; 14:163-178.
35. Hon KL, Kam WY, Leung TF, et al. Steroid fears in children with eczema. Acta Paediatr 2006; 95:1451-1455.
36. Bewley A. Expert consensus: time for a change in the way we advise our patients to use topical corticosteroids. Br J Dermatol 2008; 158:917-920.
37. Ellis RM, Koch LH, McGuire E, Williams JV. Potential barriers to adherence in pediatric dermatology. Pediatr Dermatol 2011; 28:242-244.
38. Sandoval LF, Feldman SR. Topical corticosteroids. In: Koo JY, Levin EC, Leon A, Wu JJ, Lebwohl MG, editors. Mild to moderate psoriasis, 3rd ed. Boca Raton, FL: CRC Press; 2014. pp. 21-36.
39. Murase JE, Heller MM, Butler DC. Safety of dermatologic medications in pregnancy and lactation: Part I. Pregnancy. J Am Acad Dermatol 2014; 70:401-414.
40. Chi CC, Kirtschig G, Aberer W, et al. Evidence-based (S3) guideline on topical corticosteroids in pregnancy. Br J Dermatol 2011; 165:943-952.
41. Tyler KH, Zirwas MJ. Pregnancy and dermatologic therapy. J Am Acad Dermatol 2013; 68:663-671.
42. Weatherhead S, Robson SC, Reynolds NJ. Eczema in pregnancy. BMJ 2007; 335:152-154.